UA
57
4
REGN
42
-2
DRI
56
2
CMI
67
4
AES
41
2
PM
58
2
LEN
52
2
MPC
47
3
PNR
74
5
NTAP
61
-3
DGX
48
-3
BA
45
-3
HPE
70
2
PG
50
2
ADM
24
2
HSY
43
3
LEG
31
3
LNC
45
-4
WFC
80
-2
SWKS
33
-10
UA
57
4
REGN
42
-2
DRI
56
2
CMI
67
4
AES
41
2
PM
58
2
LEN
52
2
MPC
47
3
PNR
74
5
NTAP
61
-3
DGX
48
-3
BA
45
-3
HPE
70
2
PG
50
2
ADM
24
2
HSY
43
3
LEG
31
3
LNC
45
-4
WFC
80
-2
SWKS
33
-10
Financhill
Back

Insmed Vs. Alnylam Pharmaceuticals Industry Stock Comparison

Buy
61

INSM
Insmed

Last Price:
71.24
Seasonality Move:
9.95%
Sell
32

ALNY
Alnylam Pharmaceuticals

Last Price:
258.10
Seasonality Move:
10.85%
Buy
61
Insmed (INSM) is a Buy

Is Insmed a Buy, Sell or Hold?

  • The current Insmed [INSM] share price is $70.60. The Score for INSM is 61, which is 22% above its historic median score of 50, and infers lower risk than normal.
  • INSM is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Sell
32
Alnylam Pharmaceuticals (ALNY) is a Sell

Is Alnylam Pharmaceuticals a Buy, Sell or Hold?

  • The current Alnylam Pharmaceuticals [ALNY] share price is $264.47. The Score for ALNY is 32, which is 36% below its historic median score of 50, and infers higher risk than normal.
  • ALNY is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

INSM Stock Price Chart

What is Insmed's stock price today?

  • The Insmed share price today is $70.60
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and INSM is experiencing slight selling pressure.

ALNY Stock Price Chart

What is Alnylam Pharmaceuticals's stock price today?

  • The Alnylam Pharmaceuticals share price today is $264.47
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and ALNY is experiencing selling pressure, which indicates risk of future bearish movement.

INSM Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.46 Sell
Relative Strength Index (14 RSI): 47.25 Sell
Chaikin Money Flow: -145865 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (69.51 - 74.05) Sell
Bollinger Bands (100): (69.86 - 75.94) Sell

ALNY Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -2.22 Sell
Relative Strength Index (14 RSI): 40.3 Sell
Chaikin Money Flow: -604310 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (270.63 - 291.59) Sell
Bollinger Bands (100): (248.48 - 281.74) Sell

INSM Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 71.01 Sell
20-day SMA: 71.43 Sell
50-day SMA: 72.28 Sell
200-day SMA: 52.79 Buy
8-day EMA: 71 Sell
20-day EMA: 71.31 Sell
50-day EMA: 71.63 Sell
200-day EMA: 57.51 Buy

ALNY Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 271.39 Sell
20-day SMA: 281.16 Sell
50-day SMA: 274.16 Sell
200-day SMA: 209.19 Buy
8-day EMA: 272.22 Sell
20-day EMA: 275.95 Sell
50-day EMA: 272.52 Sell
200-day EMA: 230.17 Buy

Insmed Earnings Growth & INSM Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.06 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.14 per share, and an increase next year of $1.17 per share.

Alnylam Pharmaceuticals Earnings Growth & ALNY Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.86 per share, a decrease next quarter of $0.00 per share, an increase this year of $1.46 per share, and an increase next year of $0.61 per share.

Insmed Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Alnylam Pharmaceuticals Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):